Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Global Virus Network, 12901 Bruce B Downs Boulevard, Tampa, FL.
A global non-profit network of expert virologists advancing pandemic preparedness through education and training, research, and global health strategies and solutions that inform policy, foster alliances, and combat misinformation.
04/14/2026
Dr. Ronald Desrosiers (GVN; University of Miami) presented the special lecture “Lifelong Delivery of Anti-HIV Monoclonal Antibodies from a Single Day of Vector Administration” at on March 5, 2026.
He described the use of adeno-associated virus (AAV) vectors to enable long-term expression of broadly neutralizing anti-HIV monoclonal antibodies following a single administration, eliminating the need for repeated dosing and enabling sustained antibody-mediated protection.
Dr. Mihai Netea (GVN Center of Excellence Director; Radboudumc) presented the special lecture “Trained Immunity: Role of Anti-Viral Host Defense” at on March 5, 2026.
He examined how trained immunity enhances innate immune responses through functional reprogramming of immune cells, supporting early, non-specific defense against viral infections and contributing to emerging immunological strategies for pandemic preparedness.
Dr. Jean Paul Carrera (GVN; Gorgas Memorial Institute for Health Studies) presented “Emergence And Spread Of Oropouche Virus In The Darién Gap, Panama” during the Arboviral Threats session at on March 5, 2026.
He examined the emergence and spread of Oropouche virus in the Darién Gap, highlighting the role of field-based surveillance in understanding and responding to emerging arboviral threats.
Dr. Scott Weaver (GVN Center of Excellence Director; UTMB Health) presented “Eastern Equine Encephalitis And Related Alphaviruses In The Americas” during the Arboviral Threats session at on March 5, 2026.
He discussed the epidemiology and impact of Eastern equine encephalitis and related alphaviruses, emphasizing their continued threat in the Americas and the importance of surveillance and preparedness.
Dr. Lisa Ng (GVN; Agency for Science, Technology and Research (A*STAR)) presented “Frontiers In Cellular Mechanisms And Therapeutic Interventions Of Arboviral Infections” during the Arboviral Threats session at on March 5, 2026.
She examined the cellular mechanisms underlying arboviral infections and discussed therapeutic approaches aimed at improving treatment strategies for these globally significant viruses.
Applications are now open for GVN's Global Guardians for Pandemic Preparedness, with the deadline extended to April 30, 2026.
At the 2025 program, students toured the Bureau of Public Health Laboratories in Tampa and saw virologists at work with real specimens and advanced diagnostic tools.
Hosted at University of South Florida, the program offers Florida high school students the opportunity to explore virology, epidemiology, and public health through hands on learning and engagement with experts.
Program Details:
• July 20 to 24, 2026
• University of South Florida, Tampa, FL
• Open to Florida high school students in grades 9 to 12 who have completed at least one biology course
• Free to attend after a 30 dollar non refundable application fee
• Residency option available
Dr. Brett Giroir ( ) presented “Targeting Rhinovirus To Prevent COPD Exacerbations” during the Advances in Diagnostics session at on March 5, 2026.
He presented research showing how persistent viral activity, particularly rhinovirus, may contribute to COPD progression, highlighting new antiviral approaches aimed at reducing exacerbations and long-term disease burden.
Dr. Michael Berg (GVN; Abbott) presented “Phylodynamics-Guided Design Of Infectious Disease Diagnostics” during the Advances in Diagnostics session at on March 5, 2026.
He discussed how phylodynamic approaches can inform the design of infectious disease diagnostics by integrating viral evolution and sequencing data, supporting more effective detection and surveillance strategies.
Dr. Elyse Stachler (GVN; Broad Institute of MIT and Harvard) presented “Using Machine Learning To Advance The Molecular Tool-Kit” during the Advances in Diagnostics session at on March 5, 2026.
She examined how machine learning can be applied to molecular diagnostics, including the use of large-scale genomic data to improve detection capabilities and anticipate viral evolution, supporting earlier identification of emerging variants.
Dr. Wuyuan Lu (GVN Center of Excellence Director; Fudan University Shanghai Medical College) presented the special lecture “Next-Generation Inhibitors of SARS-CoV-2 Mpro – Overcome the Deficiencies of Paxlovid, and Beyond” at on March 5, 2026.
He presented research on next-generation inhibitors targeting the SARS-CoV-2 main protease (Mpro), designed to overcome limitations of existing treatments such as Paxlovid and represent a new generation of antiviral drugs against coronaviruses.
Dr. Hideki Hasegawa (GVN Board of Directors member and Center of Excellence Director; National Institute of Infectious Diseases Japan; Japan Institute for Health Security) presented “Influenza Surveillance and Vaccine” during the Influenza & RSV: Obvious Hazards for the Future session at on March 5, 2026.
He discussed the role of influenza surveillance systems and vaccine strategies in monitoring viral evolution and strengthening preparedness against seasonal and emerging influenza strains.
Dr. Michael Teng (GVN; USF Health-University of South Florida Institute for Translational Virology & Innovation) presented “RSV New Insights” during the Influenza & RSV: Obvious Hazards for the Future session at on March 5, 2026.
He shared updated insights into respiratory syncytial virus (RSV), focusing on advancing understanding of the virus and informing future prevention and treatment strategies.
Be the first to know and let us send you an email when Global Virus Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an essential and critical defense against viral disease. It is a coalition comprised of leading virologists spanning more than 20 countries worldwide, all working to advance knowledge about how viruses make us sick and to develop drugs and vaccines to prevent illness and death. No single institution in the world has expertise in all viral areas. GVN brings the best medical virologists together to leverage individual strengths and to focus global teams of scientists on key scientific problems. The power of GVN lies in its global reach, the depth of its science, and its commitment to solving viral challenges facing the human population. No other entity exists like the GVN.
Declaration of Support for a Global Virus Network
WE, EXPERTS represent Centers of Excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind.
WE AFFIRM the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation.
WE GATHER in Washington, D.C. to support goals and ideals of the Global Virus Network, a new approach to fostering true collaboration among all regions and all peoples of the world.
Seeking to improve the immediate responses to emerging vial threats, train future generations of medical virologists, and advise governments or non-governmental organizations on viral disease threats and their control, the Global Virus Network fills a critical need in international health for today and into the future.
